<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mimmun</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская иммунология</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Immunology (Russia)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1563-0625</issn><issn pub-type="epub">2313-741X</issn><publisher><publisher-name>SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15789/1563-0625-2013-3-247-254</article-id><article-id custom-type="elpub" pub-id-type="custom">mimmun-632</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>ЦИТОКИНПРОДУЦИРУЮЩИЙ ПОТЕНЦИАЛ КЛЕТОК КРОВИ И ЦИТОКИНЫ СЫВОРОТКИ БОЛЬНЫХ ХРОНИЧЕСКИМ АТРОФИЧЕСКИМ ГАСТРИТОМ</article-title><trans-title-group xml:lang="en"><trans-title>CYTOKINE-PRODUCING POTENTIAL OF BLOOD CELLS AND SERUM CYTOKINES IN PATIENTS WITH CHRONIC ATROPHIC GASTRITIS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Соснина</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Sosnina</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., ведущий научный сотрудник лаборатории физико-химической индикации иммунных процессов</p><p>630105, ул. Линейная, 43, кв. 29. Тел.: 8 (383) 226-39-20</p></bio><bio xml:lang="en"><p>PhD (Medicine), Leading Research Associate, Laboratory of Physico-Chemical Indication of Immune Processes,</p></bio><email xlink:type="simple">lpciip@211.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Михайлова</surname><given-names>Е. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Mikhailova</surname><given-names>E. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>старший научный сотрудник лаборатории физико-химической индикации иммунных процессов</p></bio><bio xml:lang="en"><p>Senior Research Associate, Laboratory of Physico-Chemical Indication of Immune Processes</p></bio><email xlink:type="simple">lpciip@211.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Аутеншлюс</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Autenshlyus</surname><given-names>A. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.б.н., профессор, заведующий лабораторией физико-химической индикации иммунных процессов</p></bio><bio xml:lang="en"><p>PhD, MD (Biology), Professor, Chief, Laboratory of Physico-Chemical Indication of Immune Processes</p></bio><email xlink:type="simple">lpciip@211.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Вараксин</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Varaksin</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>заведующий лабораторией цитокинов</p></bio><bio xml:lang="en"><p>Chief, The Cytokine Laboratory</p></bio><email xlink:type="simple">lpciip@211.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дотолева</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Dotoleva</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>врач-эндоскопист</p></bio><bio xml:lang="en"><p>Physician (Endoscopist)</p></bio><email xlink:type="simple">lpciip@211.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Михно</surname><given-names>И. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Mikhno</surname><given-names>I. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>врач-патологоанатом</p></bio><bio xml:lang="en"><p>Pathologist</p></bio><email xlink:type="simple">lpciip@211.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Агеева</surname><given-names>Т. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Ageeva</surname><given-names>T. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., профессор, профессор кафедры патологической анатомии лечебного факультета</p></bio><bio xml:lang="en"><p>MD, Professor, Department of Pathological Anatomy, Therapeutic Faculty</p></bio><email xlink:type="simple">lpciip@211.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шпагина</surname><given-names>Л. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Shpagina</surname><given-names>L. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., профессор, заведующая кафедрой госпитальной терапии и медицинской реабилитации педиатрического факультета</p></bio><bio xml:lang="en"><p>PhD, MD (Medicine), Professor, Chief, Department of Hospital Therapy and Medical Rehabilitation, Pediatric Faculty</p></bio><email xlink:type="simple">lpciip@211.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «Научно-исследовательский институт молекулярной биологии и биофизики» СО РАМН, г. Новосибирск</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Research Institute of Molecular Biology and Biophysics, Russian Academy of Medical Sciences, Siberian Branch, Novosibirsk</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ЗАО «Вектор-Бест», Новосибирская обл.</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Vector Best Ltd, Novosibirsk Region</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ГБОУ ВПО «Новосибирский государственный медицинский университет», г. Новосибирск</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Novosibirsk State Medical University, Novosibirsk</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>24</day><month>07</month><year>2014</year></pub-date><volume>15</volume><issue>3</issue><fpage>247</fpage><lpage>254</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Соснина А.В., Михайлова Е.С., Аутеншлюс А.И., Вараксин Н.А., Дотолева Н.А., Михно И.П., Агеева Т.А., Шпагина Л.А., 2014</copyright-statement><copyright-year>2014</copyright-year><copyright-holder xml:lang="ru">Соснина А.В., Михайлова Е.С., Аутеншлюс А.И., Вараксин Н.А., Дотолева Н.А., Михно И.П., Агеева Т.А., Шпагина Л.А.</copyright-holder><copyright-holder xml:lang="en">Sosnina A.V., Mikhailova E.S., Autenshlyus A.I., Varaksin N.A., Dotoleva N.A., Mikhno I.P., Ageeva T.A., Shpagina L.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.mimmun.ru/mimmun/article/view/632">https://www.mimmun.ru/mimmun/article/view/632</self-uri><abstract><p>Резюме. Исследовали цитокинпродуцирующий потенциал клеток крови, оцениваемый по индексу влияния поликлональных активаторов, представляющему собой отношение уровня стимулированной поликлональными активаторами продукции цитокина к уровню его спонтанной продукции, а также концентрацию цитокинов в сыворотке крови больных хроническим атрофическим гастритом. Было выявлено, что у больных с дисплазией слизистой оболочки желудка повышены индексы влияния поликлональных активаторов на продукцию клетками крови TNFα, IL-1β, IL-6, IL-8 и IL- 10 и концентрация IL-8 и IL-18BP в сыворотке крови по сравнению с больными без дисплазии. Установлено, что пациенты с величинами индексов влияния поликлональных активаторов на продукцию клетками крови IL-6 не ниже 164 условных единиц и IL-8 не ниже 38 условных единиц должны быть отнесены к группе риска по развитию дисплазии эпителия слизистой оболочки желудка.</p></abstract><trans-abstract xml:lang="en"><p>Abstract. Cytokine-producing potential of peripheral blood cells was determined as a stimulation index with polyclonal activators (i.e., a cytokine production ratio of stimulated versus resting cells), as well as concentrations of cytokines were investigated in blood serum of patients with chronic atrophic gastritis. It was revealed that the stimulation indices concerning production of TNFα, IL-1β, IL-6, IL-8 and IL-10 by whole blood cells, along with serum concentrations of IL-8 and IL-18BP were increased in patients with epithelial dysplasia of stomach mucosa, as compared to patients without dysplasia. It was sahown, that the patients with higher polyclonal stimulation indices for IL-6 and IL-8 (resp., &gt; 164 and &gt; 38 arbitrary units) should be referred to a high-risk group for development of mucous epithelial dysplasia of stomach.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>продукция цитокинов</kwd><kwd>атрофический гастрит</kwd><kwd>дисплазия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>cytokine production</kwd><kwd>atrophic gastritis</kwd><kwd>dysplasia</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Абелев Г.И., Эрайзер Т.Л. На пути к пониманию природы рака // Биохимия. – 2008. – Т. 73, № 5. – С. 605-618. Abelev G.I., Erayzer T.L. Na puti k ponimaniyu prirody raka [On the path to understandig the nature of cancer]. Biokhimiya – Biochemistry, 2008, vol. 73, no. 5, pp. 605-618.</mixed-citation><mixed-citation xml:lang="en">Абелев Г.И., Эрайзер Т.Л. На пути к пониманию природы рака // Биохимия. – 2008. – Т. 73, № 5. – С. 605-618. Abelev G.I., Erayzer T.L. Na puti k ponimaniyu prirody raka [On the path to understandig the nature of cancer]. Biokhimiya – Biochemistry, 2008, vol. 73, no. 5, pp. 605-618.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Павлович И.М., Голофеевский В.Ю., Калиновский В.П. Предопухолевый потенциал хронического атрофического гастрита, ассоциированного с инфекцией Helicobacter pylori, меры профилактики // Вопросы онкологии. – 2006. – Т. 52, № 2. – С. 223-229. Pavlovich I.M., Golofeevskiy V.Yu., Kalinovskiy V.P. Predopukholevyy potentsial khronicheskogo atroficheskogo gastrita, assotsiirovannogo s infektsiey Helicobacter pylori, mery profilaktiki [Precancerous Helicobacter pylori-associated potential of atrophic gastritis Prevention]. Voprosy onkologii – Problems in oncology, 2006, vol. 52, no. 2, pp. 223-229.</mixed-citation><mixed-citation xml:lang="en">Павлович И.М., Голофеевский В.Ю., Калиновский В.П. Предопухолевый потенциал хронического атрофического гастрита, ассоциированного с инфекцией Helicobacter pylori, меры профилактики // Вопросы онкологии. – 2006. – Т. 52, № 2. – С. 223-229. Pavlovich I.M., Golofeevskiy V.Yu., Kalinovskiy V.P. Predopukholevyy potentsial khronicheskogo atroficheskogo gastrita, assotsiirovannogo s infektsiey Helicobacter pylori, mery profilaktiki [Precancerous Helicobacter pylori-associated potential of atrophic gastritis Prevention]. Voprosy onkologii – Problems in oncology, 2006, vol. 52, no. 2, pp. 223-229.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Шварцбурд П.М. Хроническое воспаление повышает риск развития эпителиальных новообразований, индуцируя предраковое микроокружение: анализ механизмов дисрегуляции // Вопросы онкологии. – 2006. – Т. 52, № 2. – С. 137-144. Shvartsburd P.M. Hronicheskoe vospalenie povyshaet risk razvitiya epitelial`nykh novoobrazovaniy, indutsiruya predrakovoe mikrookruzhenie: analiz mekhanizmov disregulyatsii [Chronic inflammation increases risk of epithelial neoplasia by inducing precancerous microenvironment: an evaluation of pathways of disregulation]. Voprosy onkologii – Problems in oncology, 2006, vol. 52, no. 2, pp. 137-144.</mixed-citation><mixed-citation xml:lang="en">Шварцбурд П.М. Хроническое воспаление повышает риск развития эпителиальных новообразований, индуцируя предраковое микроокружение: анализ механизмов дисрегуляции // Вопросы онкологии. – 2006. – Т. 52, № 2. – С. 137-144. Shvartsburd P.M. Hronicheskoe vospalenie povyshaet risk razvitiya epitelial`nykh novoobrazovaniy, indutsiruya predrakovoe mikrookruzhenie: analiz mekhanizmov disregulyatsii [Chronic inflammation increases risk of epithelial neoplasia by inducing precancerous microenvironment: an evaluation of pathways of disregulation]. Voprosy onkologii – Problems in oncology, 2006, vol. 52, no. 2, pp. 137-144.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Apte S.H., Groves P., Olver S., Baz A., Doolan D.L., Kelso A., Kienzle N. IFN-gamma inhibits IL-4- induced type 2 cytokine expression by CD8 T cells in vivo and modulates the anti-tumor response. J. Immunol., 2010, vol. 185, no. 2, pp. 998-1004.</mixed-citation><mixed-citation xml:lang="en">Apte S.H., Groves P., Olver S., Baz A., Doolan D.L., Kelso A., Kienzle N. IFN-gamma inhibits IL-4- induced type 2 cytokine expression by CD8 T cells in vivo and modulates the anti-tumor response. J. Immunol., 2010, vol. 185, no. 2, pp. 998-1004.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Botto S., Streblow D.N., DeFilippis V., White L., Kreklywich C.N., Smith P.P., Caposio P. IL-6 in human cytomegalovirus secretome promotes angiogenesis and survival of endothelial cells through the stimulation of surviving. Blood, 2011, vol. 117, no. 1, pp. 352-361.</mixed-citation><mixed-citation xml:lang="en">Botto S., Streblow D.N., DeFilippis V., White L., Kreklywich C.N., Smith P.P., Caposio P. IL-6 in human cytomegalovirus secretome promotes angiogenesis and survival of endothelial cells through the stimulation of surviving. Blood, 2011, vol. 117, no. 1, pp. 352-361.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Canetti C.A., Leung B.P., Culshaw S., McInnes I.B., Cunha F.Q., Liew F.Y. IL-18 enhances collageninduced arthritis by recruiting neutrophils via TNF-alpha and leukotriene B4. J. Immunol., 2003, vol. 171, no. 2, pp. 1009-1015.</mixed-citation><mixed-citation xml:lang="en">Canetti C.A., Leung B.P., Culshaw S., McInnes I.B., Cunha F.Q., Liew F.Y. IL-18 enhances collageninduced arthritis by recruiting neutrophils via TNF-alpha and leukotriene B4. J. Immunol., 2003, vol. 171, no. 2, pp. 1009-1015.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Correa P. Human gastric carcinogenesis: a multistep and multifactorial process – First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res., 1992, vol. 52, no. 24, pp. 6735-6740.</mixed-citation><mixed-citation xml:lang="en">Correa P. Human gastric carcinogenesis: a multistep and multifactorial process – First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res., 1992, vol. 52, no. 24, pp. 6735-6740.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Dinarello C.A., Novick D., Rubinstein M., Lonnemann G. Interleukin 18 and interleukin 18 binding protein: possible role in immunosuppression of chronic renal failure. Blood Purif., 2003, vol. 21, no. 3, pp. 258-270.</mixed-citation><mixed-citation xml:lang="en">Dinarello C.A., Novick D., Rubinstein M., Lonnemann G. Interleukin 18 and interleukin 18 binding protein: possible role in immunosuppression of chronic renal failure. Blood Purif., 2003, vol. 21, no. 3, pp. 258-270.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Dzierzanowska-Fangrat K., Michalkiewicz J., Cielecka-Kuszyk J., Nowak M., Celinska-Cedro D., Rozynek E., Dzierzanowska D., Crabtree J.E. Enhanced gastric IL-18 mRNA expression in Helicobacter pylori-infected children is associated with macrophage infiltration, IL-8, and IL-1 beta mRNA expression. Eur. J. Gastroenterol. Hepatol., 2008, vol. 20, no. 4, pp. 314-319.</mixed-citation><mixed-citation xml:lang="en">Dzierzanowska-Fangrat K., Michalkiewicz J., Cielecka-Kuszyk J., Nowak M., Celinska-Cedro D., Rozynek E., Dzierzanowska D., Crabtree J.E. Enhanced gastric IL-18 mRNA expression in Helicobacter pylori-infected children is associated with macrophage infiltration, IL-8, and IL-1 beta mRNA expression. Eur. J. Gastroenterol. Hepatol., 2008, vol. 20, no. 4, pp. 314-319.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Evans C., Morrison I., Heriot A.G., Bartlett J.B., Finlayson C., Dalgleish A.G., Kumar D. The correlation between colorectal cancer rates of proliferation and apoptosis and systemic cytokine levels; plus their influence upon survival. Br. J. Cancer, 2006, vol. 94, no. 10, pp. 1412-1419.</mixed-citation><mixed-citation xml:lang="en">Evans C., Morrison I., Heriot A.G., Bartlett J.B., Finlayson C., Dalgleish A.G., Kumar D. The correlation between colorectal cancer rates of proliferation and apoptosis and systemic cytokine levels; plus their influence upon survival. Br. J. Cancer, 2006, vol. 94, no. 10, pp. 1412-1419.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Fenton J.I., Birmingham J.M. Adipokine regulation of colon cancer: adiponectin attenuates interleukin-6-induced colon carcinoma cell proliferation via STAT-3. Mol. Carcinog., 2010, vol. 49, no. 7, pp. 700-709.</mixed-citation><mixed-citation xml:lang="en">Fenton J.I., Birmingham J.M. Adipokine regulation of colon cancer: adiponectin attenuates interleukin-6-induced colon carcinoma cell proliferation via STAT-3. Mol. Carcinog., 2010, vol. 49, no. 7, pp. 700-709.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Fujita K., Ewing C.M., Isaacs W.B., Pavlovich C.P. Immunomodulatory IL-18 binding protein is produced by prostate cancer cells and its levels in urine and serum correlate with tumor status. Int. J. Cancer, 2011, vol. 129, no. 2, pp. 424-432.</mixed-citation><mixed-citation xml:lang="en">Fujita K., Ewing C.M., Isaacs W.B., Pavlovich C.P. Immunomodulatory IL-18 binding protein is produced by prostate cancer cells and its levels in urine and serum correlate with tumor status. Int. J. Cancer, 2011, vol. 129, no. 2, pp. 424-432.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Galley H.F., El Sakka N.E., Webster N.R., Lowes D.A., Cuthbertson B.H. Activated protein C inhibits chemotaxis and interleukin-6 release by human neutrophils without affecting other neutrophil functions. Br. J. Anaesth., 2008, vol. 100, no. 6, pp. 815-819.</mixed-citation><mixed-citation xml:lang="en">Galley H.F., El Sakka N.E., Webster N.R., Lowes D.A., Cuthbertson B.H. Activated protein C inhibits chemotaxis and interleukin-6 release by human neutrophils without affecting other neutrophil functions. Br. J. Anaesth., 2008, vol. 100, no. 6, pp. 815-819.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Jablonska E., Jablonski J. Effect of IL-18 on the release of IL-6 and its soluble receptors: sIL-6Ralpha and sgp130 by human neutrophils. Immunol. Invest., 2002, vol. 31, no. 3-4, pp. 159-167.</mixed-citation><mixed-citation xml:lang="en">Jablonska E., Jablonski J. Effect of IL-18 on the release of IL-6 and its soluble receptors: sIL-6Ralpha and sgp130 by human neutrophils. Immunol. Invest., 2002, vol. 31, no. 3-4, pp. 159-167.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Kang T.H., Mao C.P., He L., Tsai Y.C., Liu K., La V., Wu T.C., Hung C.F. Tumor-targeted delivery of IL-2 by NKG2D leads to accumulation of antigen-specific CD8+ T cells in the tumor loci and enhanced antitumor effects. PLoS One, 2012, vol. 7, no. 4, e35141 p.</mixed-citation><mixed-citation xml:lang="en">Kang T.H., Mao C.P., He L., Tsai Y.C., Liu K., La V., Wu T.C., Hung C.F. Tumor-targeted delivery of IL-2 by NKG2D leads to accumulation of antigen-specific CD8+ T cells in the tumor loci and enhanced antitumor effects. PLoS One, 2012, vol. 7, no. 4, e35141 p.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Karthikeyan B., Kalishwaralal K., Sheikpranbabu S., Deepak V., Haribalaganesh R., Gurunathan S. Gold nanoparticles downregulate VEGF-and IL-1β-induced cell proliferation through Src kinase in retinal pigment epithelial cells. Exp. Eye Res., 2010, vol. 91, no. 5, pp. 769-778.</mixed-citation><mixed-citation xml:lang="en">Karthikeyan B., Kalishwaralal K., Sheikpranbabu S., Deepak V., Haribalaganesh R., Gurunathan S. Gold nanoparticles downregulate VEGF-and IL-1β-induced cell proliferation through Src kinase in retinal pigment epithelial cells. Exp. Eye Res., 2010, vol. 91, no. 5, pp. 769-778.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Kim J., Kim C., Kim T.S., Bang S.I., Yang Y., Park H., Cho D. IL-18 enhances thrombospondin-1 production in human gastric cancer via JNK pathway. Biochem. Biophys. Res. Commun., 2006, vol. 344, no. 4, pp. 1284-1289.</mixed-citation><mixed-citation xml:lang="en">Kim J., Kim C., Kim T.S., Bang S.I., Yang Y., Park H., Cho D. IL-18 enhances thrombospondin-1 production in human gastric cancer via JNK pathway. Biochem. Biophys. Res. Commun., 2006, vol. 344, no. 4, pp. 1284-1289.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Kim K.E., Song H., Hahm C., Yoon S.Y., Park S., Lee H.R., Hur D.Y., Kim T., Kim C.H., Bang S.I., Bang J.W., Park H., Cho D.H. Expression of ADAM33 is a novel regulatory mechanism in IL-18-secreted process in gastric cancer. J. Immunol., 2009, vol. 182, no. 6, pp. 3548-3555.</mixed-citation><mixed-citation xml:lang="en">Kim K.E., Song H., Hahm C., Yoon S.Y., Park S., Lee H.R., Hur D.Y., Kim T., Kim C.H., Bang S.I., Bang J.W., Park H., Cho D.H. Expression of ADAM33 is a novel regulatory mechanism in IL-18-secreted process in gastric cancer. J. Immunol., 2009, vol. 182, no. 6, pp. 3548-3555.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Min Y.G., Rhee C.S., Kwon S.H., Lee K.S., Yun J.B. Effects of IL-1 beta, TNF-alpha, and TGF-beta on proliferation of human nasal epithelial cells in vitro. Am. J. Rhinol., 1998, vol. 12, no. 4, pp. 279-282.</mixed-citation><mixed-citation xml:lang="en">Min Y.G., Rhee C.S., Kwon S.H., Lee K.S., Yun J.B. Effects of IL-1 beta, TNF-alpha, and TGF-beta on proliferation of human nasal epithelial cells in vitro. Am. J. Rhinol., 1998, vol. 12, no. 4, pp. 279-282.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Multhoff G., Molls M., Radons J. Chronic inflammation in cancer development. Front. Immunol., 2011, vol. 2, pp. 98.</mixed-citation><mixed-citation xml:lang="en">Multhoff G., Molls M., Radons J. Chronic inflammation in cancer development. Front. Immunol., 2011, vol. 2, pp. 98.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Ning Y., Manegold P.C., Hong Y.K., Zhang W., Pohl A., Lurje G., Winder T., Yang D., LaBonte M.J., Wilson P.M., Ladner R.D., Lenz H.J. Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models. Int. J. Cancer., 2011, vol. 128, no. 9, pp. 2038-2049.</mixed-citation><mixed-citation xml:lang="en">Ning Y., Manegold P.C., Hong Y.K., Zhang W., Pohl A., Lurje G., Winder T., Yang D., LaBonte M.J., Wilson P.M., Ladner R.D., Lenz H.J. Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models. Int. J. Cancer., 2011, vol. 128, no. 9, pp. 2038-2049.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Paulukat J., Bosmann M., Nold M., Garkisch S., Kampfer H., Frank S., Raedle J., Zeuzem S., Pfeilschifter J., Muhl H. Expression and release of IL-18 binding protein in response to IFN-gamma. J. Immunol., 2001, vol. 167, no. 12, pp. 7038-7043.</mixed-citation><mixed-citation xml:lang="en">Paulukat J., Bosmann M., Nold M., Garkisch S., Kampfer H., Frank S., Raedle J., Zeuzem S., Pfeilschifter J., Muhl H. Expression and release of IL-18 binding protein in response to IFN-gamma. J. Immunol., 2001, vol. 167, no. 12, pp. 7038-7043.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Ruegg C. Leukocytes, inflammation, and angiogenesis in cancer: fatal attractions. J. Leukoc. Biol., 2006, vol. 80, no. 4, pp. 682-684.</mixed-citation><mixed-citation xml:lang="en">Ruegg C. Leukocytes, inflammation, and angiogenesis in cancer: fatal attractions. J. Leukoc. Biol., 2006, vol. 80, no. 4, pp. 682-684.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Stein P., Weber M., Prufer S., Schmid B., Schmitt E., Probst H.C., Waisman A., Langguth P., Schild H., Radsak M.P. Regulatory T cells and IL-10 independently counterregulate cytotoxic T lymphocyte responses induced by transcutaneous immunization. PLoS One, 2011, vol. 6, no. 11, e27911 p.</mixed-citation><mixed-citation xml:lang="en">Stein P., Weber M., Prufer S., Schmid B., Schmitt E., Probst H.C., Waisman A., Langguth P., Schild H., Radsak M.P. Regulatory T cells and IL-10 independently counterregulate cytotoxic T lymphocyte responses induced by transcutaneous immunization. PLoS One, 2011, vol. 6, no. 11, e27911 p.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Tanno T., Matsui W. Development and maintenance of cancer stem cells under chronic inflammation. J. Nihon. Med. Sch., 2011, vol. 78, no. 3, pp. 138-145.</mixed-citation><mixed-citation xml:lang="en">Tanno T., Matsui W. Development and maintenance of cancer stem cells under chronic inflammation. J. Nihon. Med. Sch., 2011, vol. 78, no. 3, pp. 138-145.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Vannella L., Lahner E., Annibale B. Risk for gastric neoplasias in patients with chronic atrophic gastritis: a critical reappraisal. World J. Gastroenterol., 2012, vol. 18, no. 12, pp. 1279-1285.</mixed-citation><mixed-citation xml:lang="en">Vannella L., Lahner E., Annibale B. Risk for gastric neoplasias in patients with chronic atrophic gastritis: a critical reappraisal. World J. Gastroenterol., 2012, vol. 18, no. 12, pp. 1279-1285.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Wheelhouse N.M., Chan Y.S., Gillies S.E., Caldwell H., Ross J.A., Harrison D.J., Prost S. TNF-alpha induced DNA damage in primary murine hepatocytes. Int. J. Mol. Med., 2003, vol. 12, no. 6, pp. 889-894.</mixed-citation><mixed-citation xml:lang="en">Wheelhouse N.M., Chan Y.S., Gillies S.E., Caldwell H., Ross J.A., Harrison D.J., Prost S. TNF-alpha induced DNA damage in primary murine hepatocytes. Int. J. Mol. Med., 2003, vol. 12, no. 6, pp. 889-894.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Yoo J.K., Kwon H., Khil L.Y., Zhang L., Jun H.S., Yoon J.W. IL-18 induces monocyte chemotactic protein-1 production in macrophages through the phosphatidylinositol 3-kinase/Akt and MEK/ERK1/2 pathways. J. Immunol., 2005, vol. 175, no. 12, pp. 8280-8286.</mixed-citation><mixed-citation xml:lang="en">Yoo J.K., Kwon H., Khil L.Y., Zhang L., Jun H.S., Yoon J.W. IL-18 induces monocyte chemotactic protein-1 production in macrophages through the phosphatidylinositol 3-kinase/Akt and MEK/ERK1/2 pathways. J. Immunol., 2005, vol. 175, no. 12, pp. 8280-8286.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang L., Hou Y., Wu K., Li D. Comparative proteomics analysis of chronic atrophic gastritis: changes of protein expression in chronic atrophic gastritis without Helicobacter pylori infection. Braz. J. Med. Biol. Res., 2012, vol. 45, no. 3, pp. 273-283.</mixed-citation><mixed-citation xml:lang="en">Zhang L., Hou Y., Wu K., Li D. Comparative proteomics analysis of chronic atrophic gastritis: changes of protein expression in chronic atrophic gastritis without Helicobacter pylori infection. Braz. J. Med. Biol. Res., 2012, vol. 45, no. 3, pp. 273-283.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
